Nadège Delacourt

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Gilles Darcis, Anna Kula, Sophie Bouchat et al. · PLoS Pathogens · 2015 · 279 citations · Full text

Latency-reversing Agent Combinations, Immunology, Hiv-1 Eradication +22

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates <scp>HIV</scp> ‐1

Sophie Bouchat, Nadège Delacourt, Anna Kula et al. · EMBO Molecular Medicine · 2015 · 84 citations · Full text

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line

Amit Kumar, Wasim Abbas, Laurence Colin et al. · Scientific Reports · 2016 · 41 citations · Full text

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir

Gilles Darcis, Sophie Bouchat, Anna Kula et al. · AIDS · 2016 · 39 citations · Full text

Proceedings of the Frontiers of Retrovirology Conference 2016

Irena Zurnic, Sylvia Hütter, Ute Lehmann et al. · Retrovirology · 2016 · 37 citations · Full text